Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Return on Sales (2019 - 2025)

Silo Pharma's Return on Sales history spans 7 years, with the latest figure at 61.61% for Q3 2025.

  • For Q3 2025, Return on Sales fell 1008.0% year-over-year to 61.61%; the TTM value through Sep 2025 reached 70.41%, down 1890.0%, while the annual FY2024 figure was 60.93%, 5996.0% down from the prior year.
  • Return on Sales for Q3 2025 was 61.61% at Silo Pharma, up from 66.81% in the prior quarter.
  • Across five years, Return on Sales topped out at 1563.86% in Q4 2021 and bottomed at 100.57% in Q1 2023.
  • The 5-year median for Return on Sales is 44.47% (2024), against an average of 55.67%.
  • The largest annual shift saw Return on Sales soared 159101bps in 2021 before it crashed -156387bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 1563.86% in 2021, then tumbled by -100bps to 0.01% in 2022, then tumbled by -612856bps to 58.34% in 2023, then crashed by -65bps to 96.01% in 2024, then soared by 36bps to 61.61% in 2025.
  • Per Business Quant, the three most recent readings for SILO's Return on Sales are 61.61% (Q3 2025), 66.81% (Q2 2025), and 57.22% (Q1 2025).